National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 6/11/2021 release of VAERS data:

Found 332 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome



Case Details

This is page 11 out of 34

Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next


VAERS ID: 1161162 (history)  
Form: Version 2.0  
Age: 82.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-02-05
Onset:2021-03-01
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 013M20A / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Anaemia, Anti-cyclic citrullinated peptide antibody, Asthenia, Blood creatine phosphokinase normal, Blood thyroid stimulating hormone decreased, C-reactive protein normal, CSF culture negative, CSF glucose normal, CSF protein increased, CSF red blood cell count positive, CSF white blood cell count increased, Dementia, Electroencephalogram abnormal, Fatigue, Gait disturbance, Grip strength decreased, Guillain-Barre syndrome, Hyperlipidaemia, Hypertension, Hypoaesthesia, Hypofibrinogenaemia, Hypokalaemia, Loss of personal independence in daily activities, Magnetic resonance imaging head normal, Mobility decreased, Pain in extremity, Rheumatoid factor, Scan with contrast normal, Thrombocytopenia
SMQs:, Liver-related coagulation and bleeding disturbances (narrow), Dyslipidaemia (narrow), Haematopoietic erythropenia (broad), Haematopoietic thrombocytopenia (narrow), Peripheral neuropathy (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Hypertension (narrow), Demyelination (narrow), Hypothyroidism (broad), Hyperthyroidism (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Lipodystrophy (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Hypokalaemia (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 31 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Home aller care, Flare-up/Seasonal Use amLODIPine 2.5 mg oral tablet, 2.5 mg= 1 tab(s), PO, Daily, 3 refills ARICEPT 10 mg oral tablet, 10 mg= 1 tab(s), PO, Every Bedtime, 3 refills COQ10, See Instructions hydroCHLOROthiazide 25 mg o
Current Illness:
Preexisting Conditions: Ongoing Allergic rhinitis Duodenal ulcer Hyperlipidemia Hypertension Mild dementia
Allergies: Allergies azithromycin (Loss of strenght) doxycycline (Loss strenght) losartan (Diarrhea) atorvastatin (Myalgia) PABA (Rash)
Diagnostic Lab Data: Pertinent Procedures, Diagnostics and Labs CRP <3.0 CPK 96 TSH 1.71 ANA Multiplex screen neg Rheumatoid Factor 47IU/mL AntiCCP <0.5 IgA 330 UA neg Anti-GQ1, IGA pending <1:100 CSF 3/3/2021 glucose 69 protein 214 RBC 239 WBC 16 (gran 2%, sm mono 66% lg mono 32%) path no malignant cells culture no growth MRI of the brain with intravenous contrast. 3/3/2021 1. No acute intracranial abnormality. 2. No evidence of recent infarct. No abnormal parenchymal enhancement. 3. Similar to mild progression of the moderate microvascular changes as described above. EMG 3/9 Concentric needle examination of right arm and leg is remarkable for the following: 1. No abnormal spontaneous activity except a single fibrillation potential in right gastrocnemius muscle. 2. There was voluntary motor unit potentials with long duration, high amplitude and reduced recruitment in right tibialis anterior, gastrocnemius and vastus medialis muscles. There were voluntary motor unit potentials with normal duration, amplitude and reduced recruitment in right flexor carpi radialis and 1st dorsal interosseus muscles. Nerve conduction study is remarkable for the following: 1. Severely reduced conduction velocities, prolonged distal latencies with normal amplitudes on right median, ulnar and peroneal motor over TA. 2. Absent right peroneal motor over Extensor digitorum brevis and absent right tibial motor conduction study. 3. Prolonged distal latencies and normal amplitudes on right superficial radial and ulnar sensory conduction studies. Prolonged distal latency with mildly reduced amplitude on right median sensory conduction study. 4. Absent right sural and superficial peroneal sensory responses. 5. Absent F-reflex on right median motor study. Axon reflex was seen. 6. Normal F-wave latency on right ulnar motor study.
CDC Split Type:

Write-up: 82 year old male with history of hypertension, hyperlipidemia, mild dementia presented with progressive worsening weakness over the past 2-3 weeks. Patient reported that he has noticed whole body weakness that has progressively worsened over the past few days. Reported that he has noticed feeling weak, fatigue and requiring more energy to do his daily activities over the past few weeks. He went to his PCP''s office yesterday and had laboratory tests for further evaluation. Initially his PCP thought he might have PMR since he had bilateral UE soreness. However, the labs returned reassuring and does not seem to suggest the diagnosis of PMR. Since yesterday, he has noticed worsening of his weakness. Reported that last week, he was still able to play golf. Today, he was unable to get out of his car or get up from a sitting position without help. Associated with unsteady and poor gait. And reported that he has numbness in both hands and feels like his grip is weak. Denied fever, chills, nausea, vomiting, diarrhea, constipation, chest pain, shortness of breath, headache, vision changes, no urinary/fecal retention or urinary/fecal incontinence. Primary Discharge Diagnoses 1. Guillain Barr syndrome., 03/16/2021 Secondary Diagnoses: Guillain Barre Syndrome (AIDP) Hypofibrinogenemia Thrombocytopenia and Anemia, have been fairly stable for more than a week Hypokalemia Hyperlipidemia Hypertension, BPs controlled Mild dementia


VAERS ID: 1162021 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Texas  
Vaccinated:2021-01-09
Onset:2021-02-06
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Asthenia, Bell's palsy, Guillain-Barre syndrome, Headache, Lumbar puncture, Pain in extremity, Paraesthesia, Sluggishness
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No reported medical history)
Allergies:
Diagnostic Lab Data: Test Date: 20210216; Test Name: Lumbar puncture; Test Result: Inconclusive ; Result Unstructured Data: Guillen Barre Syndrome
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Bilateral facial bell''s palsy; Guillain Barre syndrome; Weakness in arms and legs; the tingling got worse and he had a lot more weakness in arms and legs; his arm started tingling; Headache/strrong headache; Arm ached; Bit sluggish; A spontaneous report was received from a consumer concerning a male patient of unspecified age who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced the events bilateral facial Bell''s palsy/Bell''s palsy, bit sluggish, arm ached, Tingling in arms and legs, weakness in arms and legs, Guillain barre syndrome and headache. The patient''s medical history was not provided. No relevant concomitant product use was reported. On 09 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 06 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. Patient went to the ER. On 06 Feb 2021, the patient experienced bit sluggish, arm ached and head ache. On 12 Feb 2021, the patient developed a strong headache. On 13 Feb 2021, the patient developed tingling in his arms. On 14 Feb 2021, patient had tingling in his feet. On 15 Feb 2021, the tingling got worsened and patient experienced a lot more weakness in arms and legs. On 16 Feb 2021, the patient was diagnosed with Guillen Barre Syndrome. On unknown date ,patient developed bilateral facial Bell''s palsy. Laboratory details included CAT scan and lumbar puncture. Treatment received for the events, included IVIG treatment and steroids. Action taken with the with mRNA-1273 in response to the event is not applicable. The outcome of the events bit sluggish and arm ached were resolved . The outcome of the events headache, his arm started tingling, feel also started tingling, weakness in arms and legs, Guillain barre syndrome and bilateral facial Bell''s palsy were unknown.; Reporter''s Comments: Based on the current available information which includes a temporal association between the use of the product and onset of the events, and excluding other etiologies, a causal relationship cannot be excluded


VAERS ID: 1163209 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Male  
Location: Connecticut  
Vaccinated:2021-03-05
Onset:2021-03-17
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-04-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Paralysis, Pneumonia, Vaccination complication
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: Numbness in extremities, paralysis full body. Pneumonia left lung. Now diagnosed with Guillain-Barre syndrome, due to reaction to covid-19 vaccine


VAERS ID: 1163748 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Female  
Location: Indiana  
Vaccinated:2021-03-16
Onset:2021-03-19
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 003Q21A / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: CSF protein increased, CSF white blood cell count negative, Guillain-Barre syndrome, Lumbar puncture abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol, atorvastatin, breo ellipta, Bevespi aerosphere, levothyroxine, lisinopril, melatonin, metoprolol succinate, pramipexole, sertraline, trazodone
Current Illness:
Preexisting Conditions: Hypothyroidism, Esophageal reflux, insomnia, COPD, anxiety, aortic stenosis, vitamin D deficiency, hypertension, hyperlipidemia, obstructive sleep apnea, mitral stenosis, restless leg syndrome, alcohol use/abuse
Allergies: Wellbutrin, penicillin''s
Diagnostic Lab Data: Lumbar puncture with cytoalbuminological dissociation
CDC Split Type:

Write-up: Progressive symptoms highly consistent with guillian barre syndrome


VAERS ID: 1166194 (history)  
Form: Version 2.0  
Age: 22.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-03-16
Onset:2021-03-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 047AZ1A / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Blood test normal, CSF protein increased, Fatigue, Gait disturbance, Guillain-Barre syndrome, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging normal, Musculoskeletal stiffness, Myalgia, Pain in extremity, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Colazal, Cymbalta, Protonic
Current Illness: none
Preexisting Conditions: Fibromyalgia, mild ulcerative colitis
Allergies: none
Diagnostic Lab Data: 3/31/21 -blood work all within normal parameters. 4/1/21 - Lumbar puncture showed elevated proteins, MRI was within normal parameters
CDC Split Type:

Write-up: Patient had his 1st dose of the Moderna vaccine & developed commonly reported side effects, sore arm & fatigue shortly after the vaccine was administered. As the week continued past 48 hours post injection period, he was experiencing extreme fatigue & muscle aches. On the morning of 3/29 his feet were tingling & his legs were stiff. When he woke up on 3/30 the stiffness in his legs & the tingling increased to the point where walking became difficult. Finally on the morning of 3/31 he could not walk without assistance. His PCP said to take him to the emergency room. Patient was admitted to Medical Center with the suspicion of Guillain Barre Syndrome. A lumbar puncture confirmed Guillain Barre on 4/1/21 and a 5 day course of IVIG was started immediately after confirmation of diagnosis.


VAERS ID: 1166746 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-03-14
Onset:2021-03-26
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: vitamin D, vitamin B-12
Current Illness:
Preexisting Conditions: depression, vitamin D deficiency
Allergies: no known allergies
Diagnostic Lab Data:
CDC Split Type:

Write-up: Symptoms started as numbness and weakness in her feet which progressed to her hands, and eventually whole body. Diagnosis is Guillain-Barre syndrome. Remains hospitalized and receiving IVIG.


VAERS ID: 1172339 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-03-11
Onset:2021-03-18
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1802072 / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: amLODIPine aspirin 81 mg Tablet, diazePAM gabapentin hydroCHLOROthiazide losartan nitroglycerin omeprazole oxyCODONE-acetaminophen potassium chloride SA (K-DUR) tiZANidine
Current Illness:
Preexisting Conditions: Type 2 DM, GERD, Chronic low back pain
Allergies: NKA
Diagnostic Lab Data: Lumbar puncture on 04/03/21
CDC Split Type:

Write-up: A week after the patient had the vaccine he developed weakness with numbness in the lower extremities. Patient continued to get worse and was admitted on 04/03 with concerns for Guillain-Barr? syndrome ( GBS). Patient is currently getting treatment for GBS.


VAERS ID: 1172503 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Male  
Location: New York  
Vaccinated:2021-03-11
Onset:2021-03-25
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-04-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1802072 / 1 RA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Asthenia, CSF protein increased, Guillain-Barre syndrome, Lumbar puncture abnormal, White blood cell count decreased
SMQs:, Haematopoietic leukopenia (narrow), Peripheral neuropathy (narrow), Systemic lupus erythematosus (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Valsartan-HCTZ, rosuvastain, ASA
Current Illness: None
Preexisting Conditions: HTN, HLD
Allergies: No known allergies
Diagnostic Lab Data: Lumbar puncture with CSF protein 219, WBC 3
CDC Split Type:

Write-up: Patient with progressive ascending weakness over 2 weeks. Diagnosed with Guillain-Barre Syndrome.


VAERS ID: 1175483 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Wisconsin  
Vaccinated:2021-03-16
Onset:2021-03-26
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 046A21A / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Guillain-Barre syndrome, Magnetic resonance imaging spinal abnormal, Paraesthesia
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 11 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: hydrocodone/acetaminophen PO, metronidazole PO, ceftriaxone IV, acetaminophen PO, insulin lispro SC, atorvastatin PO, multivitamin PO
Current Illness: Recently discharged after hospitalization for lung abscess, pleural empyema s/p right thoracoscopy and partial decortication on 3/11/21.
Preexisting Conditions: DM1, hyperlipidemia
Allergies: dust, mold
Diagnostic Lab Data: MRI-spine (3/26/21): some enhancement of the cauda equina.
CDC Split Type:

Write-up: Patient was immunized on 3/16/21 shortly after being discharged from the hospital. He was readmitted with abdominal pain and complaints of bilateral hand tingling. Neurology was consulted and working diagnosis was Guillain-Barre Syndrome (GBS). Patient was given a 5 dose series of IVIG 0.4g/kg.


VAERS ID: 1177991 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-03-01
Onset:2021-03-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Severe Guillain Barre Syndrome


Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=11&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166